Antiverse
Cardiff, United Kingdom antiverse.io
From their website, Nov 2026
Work here? Claim this listing
About
Antiverse designs functional biologics for GPCRs and other challenging transmembrane targets using in-house AI and lab science. It is headquartered in Cardiff, UK, with offices in Boston, USA and Prague, Czechia.
Services
Antibody and nanobody discovery
Generates antibody and nanobody sequences de novo from target sequence alone, without requiring an existing ligand, binder, or prior campaign data.
Functional validation
Runs confirmed binders through functional assays against the disease-relevant receptor and feeds results back into the model.
Native context screening
Pans candidates against target receptors expressed in engineered cell lines in their native membrane environment.
Multiparametric developability triage
Clusters binders by epitope and developability properties to deliver a diverse, developable panel.
Developability optimisation
Uses ML models to filter for therapeutic characteristics such as safety, stability, and cross-reactivity from the first iteration.
De novo antibody and nanobody discovery
Generates antibody and nanobody sequences de novo from target sequence alone, without requiring an existing ligand, binder, or prior campaign data.
Generative AI design
Uses generative AI to design biologics from target sequence alone and explore novel chemical space, sequence, or structure-based designs.
Native membrane screening
Pans candidates against target receptors expressed in precisely engineered cell lines in their native membrane environment.
Developability triage
Clusters binders by epitope and developability properties to return a diverse, developable panel.
AI and ML-guided binder discovery
Uses proprietary AI and ML models to identify high-potential binders for challenging GPCR and transmembrane targets.
- Turnaround
- 1 month
- What to send
- Target sequence alone
Capabilities
- Assays and studies
- Antibodies · Functional assays · Native membrane screening · Developability triage · Cell-based functional assays · Epitope-specific functional prediction
- Scale and capacity
- >240 proprietary stable cell lines for GPCRs and ion channels
- Therapeutic areas
- GPCR therapeutics · GPCRs · Transmembrane targets
Modalities and species
- Modalities
- Antibody
- Species and models
- Human stable cell lines · GPCRs · Ion channels
Industries served
- Biotech
- Pharma
- Life science
Company
- Founded
- 2017
Locations
- Based in
- Cardiff, United Kingdom
- Sites
- Cardiff, UK · Boston, USA · Prague, Czechia
Contacts
- General enquiry
- info@antiverse.io on their site
Similar labs
Work here? Claim this listing